Collaborative research proposals using this discovery platform.
D35LNPs stimulate TLR9 and significantly induce the release of IFN-α from plasmacytoid dendritic cells, thereby strongly enhancing systemic immunity
This mycobacterial glycolipid compound is an adjuvant and antigen that activates T cells, being expected to be a novel lipid vaccine.
Using vesicles derived from the cell membrane of target bacteria allows for highly species-specific treatment
Single-round infectious rotavirus created by reverse genetics.
Overcoming the challenges of mRNA medicine by improving translation efficiency
Original method and hepatocyte reproduced hepatobiliary function
Excellent Vaccine Development/Research Platform